Current Procedural Terminology (CPT) code 66174 represents the transluminal dilation of the aqueous outflow canal, a minimally invasive glaucoma surgery (MIGS) procedure. As a regulatory reference, this code requires precise clinical documentation of the mechanical dilation of the Schlemm’s canal—typically performed with a catheter or similar device—to facilitate aqueous humor drainage. Accurate reporting demands adherence to global period guidelines, bundling edits, and specific documentation requirements to ensure reimbursement and audit compliance in ophthalmic surgical practices.
Overview of CPT Code 66174
CPT code 66174 is defined as "Transluminal dilation of aqueous outflow canal; without retention of device or stent." This procedure, often referred to as canaloplasty, is designed to reduce intraocular pressure in patients diagnosed with open-angle glaucoma. Unlike traditional filtering surgeries like trabeculectomy, 66174 targets the natural outflow pathway of the eye, aiming to improve the physiological drainage of aqueous humor through the trabecular meshwork and Schlemm’s canal.
From a regulatory standpoint, the code is categorized under the "Ocular Adnexa" and "Anterior Segment" subsections of the Eye and Ocular Adnexa CPT index. Because the procedure involves the dilation of the canal without the permanent implantation of a device, it is distinct from procedures coded under 66183 (aqueous shunt) or 66172 (fistulization of sclera for glaucoma). Surgeons and billing departments must verify that the surgical report explicitly describes the circumferential catheterization or dilation of the canal to justify the use of 66174 over lower-complexity procedures.
Regulatory Framework and Coding Guidelines
The regulatory landscape for ophthalmic surgical coding is primarily governed by the American Medical Association (AMA) CPT Editorial Panel and the Centers for Medicare & Medicaid Services (CMS) National Correct Coding Initiative (NCCI) edits. For 66174, the regulatory reference documentation must reflect the specific surgical steps that distinguish "transluminal dilation" from other interventions.
NCCI Edits and Bundling
One of the most critical aspects of 66174 compliance is understanding its relationship with concurrent procedures. Under NCCI guidelines, certain surgical maneuvers are considered integral to the primary procedure and cannot be billed separately. For instance, when 66174 is performed during the same operative session as cataract surgery (e.g., 66984), it is often subject to payment modifiers.
Historically and through 2026, payers have closely scrutinized the co-surgery of glaucoma procedures with phacoemulsification. Coders must use modifier -51 (multiple procedures) or -59 (distinct procedural service), depending on the specific payer policy, to clarify that the dilation of the aqueous outflow canal was an independent surgical action necessitated by the patient’s glaucoma, rather than an incidental part of the cataract removal.
Clinical Documentation Requirements
To meet regulatory requirements, the operative report for 66174 must detail:
- Access Technique: The method used to access Schlemm’s canal (e.g., via a micro-incision or localized scleral flap).
- Device Utilization: Confirmation that the dilation was achieved via a transluminal catheter or similar device.
- Procedural Scope: Documentation of the circumferential nature of the dilation, as 66174 specifically pertains to the transluminal approach.
- Outcome: A statement regarding the restoration of canal patency, which serves as the physiological basis for the procedure.
Comparative Coding Matrix
Understanding the difference between 66174 and related glaucoma codes is essential for avoiding audit triggers. The following table illustrates the distinctions based on current CPT standards.
| CPT Code | Procedure Description | Key Technical Distinction |
|---|---|---|
| 66174 | Transluminal dilation of aqueous outflow canal | No device/stent; involves catheter-based dilation |
| 66175 | Transluminal dilation of aqueous outflow canal | Includes the insertion of a structural device/stent |
| 66172 | Fistulization of sclera for glaucoma | Full-thickness or partial-thickness scleral flap |
| 66984 | Extracapsular cataract removal | Intraocular lens replacement, distinct from glaucoma |
Preoperative and Postoperative Compliance
The global period for 66174, as dictated by the CMS Physician Fee Schedule, is generally 90 days, classifying it as a "major" surgery in terms of follow-up requirements. This means that all routine postoperative visits and care related to the recovery from the 66174 procedure are included in the global fee.
Global Period Obligations
Physicians must ensure that any visit during the 90-day global period that is unrelated to the surgery—such as a visit for a condition other than glaucoma or an unrelated ocular infection—is billed with the appropriate modifier (e.g., -24). Failure to distinguish between global period care and distinct, unrelated care is a common source of claim denials and audit findings.
Medical Necessity Verification
The primary regulatory burden for 66174 lies in proving medical necessity. Documentation should clearly state:
- The patient’s failure to achieve target intraocular pressure (IOP) with maximal tolerated medical therapy.
- The presence of progressive glaucomatous optic nerve damage or visual field loss.
- The patient's inability to comply with or tolerate topical glaucoma medications.
Without these specific clinical indicators, the procedure may be deemed "elective" or "not medically necessary" by third-party payers, leading to recoupment demands.
Common Coding Errors and Troubleshooting
Practices often face challenges when coding 66174 due to the evolving nature of MIGS technology. Below are common pitfalls and recommended troubleshooting steps.
- Incorrect Code Selection: A common error is using 66174 when a stent was actually left in place. If a stent is left in the canal, the code should reflect the device insertion (66175).
- Missing Modifiers: Failing to append modifiers during combined procedures (e.g., 66174 with 66984) is a primary cause of rejected claims. Always consult the latest NCCI spreadsheet before submission.
- Documentation Deficit: If the operative note fails to mention the catheterization technique or the specific mechanical dilation of the canal, the payer may request medical records. Ensure the surgeon’s notes are as descriptive as possible regarding the "transluminal" nature of the work.
- Unbundling Violations: Attempting to charge for secondary components of the surgery, such as local anesthesia or irrigation, which are included in the global surgical package.
Frequently Asked Questions
Is CPT 66174 considered a "major" surgery for billing purposes?
Yes, CPT 66174 carries a 90-day global surgical period. This means the reimbursement covers the preoperative visit (if performed on the day of surgery), the surgery itself, and all routine follow-up care related to the recovery for 90 days following the procedure.
Can I bill for a separate office visit on the day of the 66174 procedure?
Generally, no. The global surgery package includes the decision for surgery on the day of the procedure. If you perform a significant, separately identifiable evaluation and management (E/M) service that is unrelated to the surgery, you must append modifier -25 to the E/M code, though this is rarely applicable to the surgical planning of the glaucoma procedure itself.
What should I do if the insurance company denies 66174 as "investigational"?
Verify that the medical record contains documented failure of previous interventions and clear evidence of glaucoma progression. Ensure the claim includes the correct ICD-10 codes for glaucoma that align with the specific procedural requirements. If documentation is complete, submit an appeal with the operative report and relevant clinical trials or medical guidelines supporting the efficacy of the procedure.
Does 66174 include the use of OVDs (Ophthalmic Viscosurgical Devices)?
The use of viscoelastics during the dilation process is considered part of the surgical technique and is bundled into the primary procedure code. You should not attempt to bill separately for these supplies under the current CPT guidelines for 66174.
How do I handle a scenario where 66174 is performed on both eyes?
When the procedure is performed bilaterally, append modifier -50 (bilateral procedure) to the code 66174. Be aware that reimbursement rules for bilateral procedures vary by carrier, and you should check the Medicare Physician Fee Schedule (MPFS) for the specific bilateral surgery indicator assigned to this code.
Recommendations for Compliance
To maintain clean claim submission for CPT 66174:
- Audit Documentation: Perform a monthly internal audit of 10% of your 66174 operative notes to ensure they meet the specific requirements of "transluminal" and "dilation."
- Update Billing Software: Ensure your billing platform is updated with the latest 2026 NCCI edits, as these are refreshed quarterly and can impact the bundling status of this code.
- Prior Authorization: Always verify the specific coverage criteria of the patient's insurance plan. Many private payers have established "Medical Policy" documents that are more restrictive than CMS regarding the use of MIGS procedures.
- Communication: Maintain open lines of communication between the surgical team and the billing department to ensure that the "without retention of device" aspect of the surgery is communicated accurately to the billing team before the claim is generated.
By adhering to these regulatory guidelines and maintaining rigorous documentation standards, surgical practices can ensure that their use of 66174 remains compliant with federal and private payer requirements, minimizing the risk of audits and financial penalties.
